Cargando…
Selective ALDH3A1 Inhibition by Benzimidazole Analogues Increase Mafosfamide Sensitivity in Cancer Cells
[Image: see text] Aldehyde dehydrogenase enzymes irreversibly oxidize aldehydes generated from metabolism of amino acids, fatty acids, food, smoke, additives, and xenobiotic drugs. Cyclophosphamide is one such xenobiotic used in cancer therapies. Upon activation, cyclophosphamide forms an intermedia...
Autores principales: | Parajuli, Bibek, Fishel, Melissa L., Hurley, Thomas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988914/ https://www.ncbi.nlm.nih.gov/pubmed/24387105 http://dx.doi.org/10.1021/jm401508p |
Ejemplares similares
-
Interleukin-2 receptor β chain as a possible target for low doses of mafosfamide
por: Pukhalsky, A., et al.
Publicado: (1995) -
Mafosfamide Boosts GMI-HBVac against HBV via Treg Depletion in HBV-Infected Mice
por: Lin, Qin, et al.
Publicado: (2023) -
Shiga Toxin 1, as DNA Repair Inhibitor, Synergistically Potentiates the Activity of the Anticancer Drug, Mafosfamide, on Raji Cells
por: Brigotti, Maurizio, et al.
Publicado: (2013) -
Development of Selective Inhibitors
for Aldehyde Dehydrogenases
Based on Substituted Indole-2,3-diones
por: Kimble-Hill, Ann C., et al.
Publicado: (2014) -
Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia
por: Abdallah, A, et al.
Publicado: (2002)